Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just noticed something interesting in the latest institutional holdings data. The Czech National Bank has been quietly building a position in Charles Schwab stock, adding over 67,000 shares to their portfolio. But here's what caught my eye - while some big money is moving in, the insider activity tells a different story.
Charles Schwab's own executives have been selling pretty aggressively over the past six months. Charles Schwab himself along with other top management have dumped significant stakes, with the co-chairman and other insiders collectively offloading hundreds of thousands of shares. When company insiders are selling like that, it usually makes you wonder what they know.
That said, the institutional money remains split. Price T Rowe Associates trimmed their Charles Schwab holdings by a big margin in Q4 2024, but Viking Global came in strong with a massive position increase. It's one of those situations where different players are reading the same tea leaves in completely different ways.
Analysts are mostly bullish though - multiple buy and outperform ratings on the stock, with price targets hovering around $79 median. But the insider selling combined with mixed institutional moves suggests caution might be warranted here. Worth keeping an eye on.